INTENSITY THERAPEUTICS INC (INTS) Forecast, Price Target & Analyst Ratings

NASDAQ:INTS • US45828J2024

Current stock price

5.98 USD
-0.35 (-5.53%)
At close:
5.98 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTENSITY THERAPEUTICS INC (INTS).

Forecast Snapshot

Consensus Price Target

Price Target
$74.38
+ 1,143.73% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$1.28
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$74.38
Upside
+ 1,143.73%
From current price of $5.98 to mean target of $74.38, Based on 12 analyst forecasts
Low
$37.88
Median
$76.50
High
$131.25

Price Target Revisions

1 Month
2,399.97%
3 Months
2,399.97%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for INTS. The average price target is 74.38 USD. This implies a price increase of 1143.73% is expected in the next year compared to the current price of 5.98.
The average price target has been revised upward by 2399.97% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INTS Current Analyst RatingINTS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

INTS Historical Analyst RatingsINTS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
INTS was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INTS.
In the previous month the buy percentage consensus was at a similar level.
INTS was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-20BenchmarkMaintains Speculative Buy -> Speculative Buy
2025-08-12Brookline CapitalUpgrade Hold -> Buy
2025-01-13Alliance Global PartnersInitiate Buy
2024-11-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-31HC Wainwright & Co.Initiate Buy
2024-07-11BenchmarkReiterate Speculative Buy -> Speculative Buy
2024-05-16BenchmarkReiterate Speculative Buy -> Speculative Buy
2024-03-21BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-11-14BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-08-24BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-07-18BenchmarkInitiate Speculative Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$1.28
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
76.82%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-2,400.00%
EPS (3 Months)
-2,280.95%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
INTS revenue by date.INTS revenue by date.
N/AN/AN/AN/A
1,106.36%		N/A
1,305.65%		N/A
117.02%		N/A
60.80%		N/A
35.22%		N/A
25.53%
EBITDA
YoY % growth
INTS ebitda by date.INTS ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
INTS ebit by date.INTS ebit by date.
-6.223M-8.014M
-28.77%		-7.55M
5.79%		-8.319M
-10.19%		-16.585M
-99.36%		N/A
28.39%		N/A
-6.78%		N/A
-28.19%		N/A
24.63%		N/A
105.98%		N/A
7,971.83%		N/A
5.71%		N/A
44.61%		N/A
25.37%
Operating Margin
INTS operating margin by date.INTS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
INTS eps by date.INTS eps by date.
N/AN/AN/AN/A-29.25
11.08%		N/A
70.79%		N/A
35.82%		N/A
-10.08%		N/A
96.62%		N/A
600.00%		N/A
1,375.00%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.28
76.82%		-1.45
73.73%		-1.45
55.54%		-1.45
3.66%		-1.66
-30.00%
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.892M
9.72%		-3.142M
7.44%		-3.193M
-18.03%		-3.305M
-20.92%		N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INTS Yearly Revenue VS EstimatesINTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
INTS Yearly EPS VS EstimatesINTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 10 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.50%
EPS Next 5 Year
15.27%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INTENSITY THERAPEUTICS INC / INTS Forecast FAQ

What is the price target for INTS stock?

12 analysts have analysed INTS and the average price target is 74.38 USD. This implies a price increase of 1143.73% is expected in the next year compared to the current price of 5.98.

Can you provide the consensus estimates for INTENSITY THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of INTENSITY THERAPEUTICS INC (INTS) is -1.27 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed INTENSITY THERAPEUTICS INC (INTS)?

The number of analysts covering INTENSITY THERAPEUTICS INC (INTS) is 12.